Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach.
Machine learning
Maternal risk factors
Neonatal risk factor
Random survival forest
Retinopathy of prematurity ROP
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
27
11
2023
accepted:
14
08
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
23
8
2024
Statut:
epublish
Résumé
Retinopathy of prematurity (ROP), is a preventable leading cause of blindness in infants and is a condition in which the immature retina experiences abnormal blood vessel growth. The development of ROP is multifactorial; nevertheless, the risk factors are controversial. This study aimed to identify risk factors of time to development of ROP in Iran. This historical cohort study utilized data from the hospital records of all newborns referred to the ROP department of Farabi Hospital (from 2017 to 2021) and the NICU records of infants referred from Mahdieh Hospital to Farabi Hospital. Preterm infants with birth weight (BW) ≤ 2000 g or gestational age (GA) < 34 wk, as well as selected infants with an unstable clinical course, as determined by their pediatricians or neonatologists, with BW > 2000 g or GA ≥ 34 wk. The outcome variable was the time to development of ROP (in weeks). Random survival forest was used to analyze the data. A total of 338 cases, including 676 eyes, were evaluated. The mean GA and BW of the study group were 31.59 ± 2.39 weeks and 1656.72 ± 453.80 g, respectively. According to the criteria of minimal depth and variable importance, the most significant predictors of the time to development of ROP were duration of ventilation, GA, duration of oxygen supplementation, bilirubin levels, duration of antibiotic administration, duration of Total Parenteral Nutrition (TPN), mother age, birth order, number of surfactant administration, and on time screening. The concordance index for predicting survival of the fitted model was 0.878. Our findings indicated that the duration of ventilation, GA, duration of oxygen supplementation, bilirubin levels, duration of antibiotic administration, duration of TPN, mother age, birth order, number of surfactant administrations, and on time screening are potential risk factors of prognosis of ROP. The associations between identified risk factors were mostly nonlinear. Therefore, it is recommended to consider the nature of these relationships in managing treatment and designing early interventions.
Sections du résumé
BACKGROUND
BACKGROUND
Retinopathy of prematurity (ROP), is a preventable leading cause of blindness in infants and is a condition in which the immature retina experiences abnormal blood vessel growth. The development of ROP is multifactorial; nevertheless, the risk factors are controversial. This study aimed to identify risk factors of time to development of ROP in Iran.
METHODS
METHODS
This historical cohort study utilized data from the hospital records of all newborns referred to the ROP department of Farabi Hospital (from 2017 to 2021) and the NICU records of infants referred from Mahdieh Hospital to Farabi Hospital. Preterm infants with birth weight (BW) ≤ 2000 g or gestational age (GA) < 34 wk, as well as selected infants with an unstable clinical course, as determined by their pediatricians or neonatologists, with BW > 2000 g or GA ≥ 34 wk. The outcome variable was the time to development of ROP (in weeks). Random survival forest was used to analyze the data.
RESULTS
RESULTS
A total of 338 cases, including 676 eyes, were evaluated. The mean GA and BW of the study group were 31.59 ± 2.39 weeks and 1656.72 ± 453.80 g, respectively. According to the criteria of minimal depth and variable importance, the most significant predictors of the time to development of ROP were duration of ventilation, GA, duration of oxygen supplementation, bilirubin levels, duration of antibiotic administration, duration of Total Parenteral Nutrition (TPN), mother age, birth order, number of surfactant administration, and on time screening. The concordance index for predicting survival of the fitted model was 0.878.
CONCLUSION
CONCLUSIONS
Our findings indicated that the duration of ventilation, GA, duration of oxygen supplementation, bilirubin levels, duration of antibiotic administration, duration of TPN, mother age, birth order, number of surfactant administrations, and on time screening are potential risk factors of prognosis of ROP. The associations between identified risk factors were mostly nonlinear. Therefore, it is recommended to consider the nature of these relationships in managing treatment and designing early interventions.
Identifiants
pubmed: 39180010
doi: 10.1186/s12886-024-03637-w
pii: 10.1186/s12886-024-03637-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
364Informations de copyright
© 2024. The Author(s).
Références
Abrishami M, et al. Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran. Iran Red Crescent Med J. 2013;15(3):229.
pubmed: 23984003
pmcid: 3745752
doi: 10.5812/ircmj.4513
Blencowe H, Moxon S, Gilbert C. Update on blindness due to retinopathy of prematurity globally and in India. Indian Pediatr. 2016;53:S89–92.
pubmed: 27915313
Zhang R-H, et al. Prevalence, years lived with disability, and time trends for 16 causes of blindness and vision impairment: findings highlight retinopathy of prematurity. Front Pediatr. 2022;10: 735335.
pubmed: 35359888
pmcid: 8962664
doi: 10.3389/fped.2022.735335
Khorshidifar M, et al. Incidence and risk factors of retinopathy of prematurity and utility of the national screening criteria in a tertiary center in Iran. Int J Ophthalmol. 2019;12(8):1330.
pubmed: 31456925
pmcid: 6694057
doi: 10.18240/ijo.2019.08.15
Liegl, R., A. Hellström, and L.E. Smith, Retinopathy of prematurity: the need for prevention. Eye and brain, 2016: p. 91–102.
Chen Y, et al. Incidence and risk factors of retinopathy of prematurity in two neonatal intensive care units in North and South China. Chin Med J. 2015;128(07):914–8.
pubmed: 25836612
pmcid: 4834008
doi: 10.4103/0366-6999.154294
Sood V, et al. Changing spectrum of retinopathy of prematurity (ROP) and variations among siblings of multiple gestation. The Indian Journal of Pediatrics. 2012;79:905–10.
pubmed: 22002316
doi: 10.1007/s12098-011-0574-y
Yau, G.S., et al., Incidence and risk factors for retinopathy of prematurity in multiple gestations: a Chinese population study. Medicine, 2015. 94(18).
Kleinbaum, D.G. and M. Klein, Survival analysis a self-learning text. 1996: Springer.
Ishwaran, H., et al., Random survival forests. 2008.
Lin W-C, et al. Oxygenation Fluctuations Associated with Severe Retinopathy of Prematurity: Insights from a Multimodal Deep Learning Approach. Ophthalmology Science. 2024;4(2): 100417.
pubmed: 38059124
doi: 10.1016/j.xops.2023.100417
Drazdienė N, et al. Multifactorial risk environment for retinopathy of prematurity. Acta Medica Lituanica. 2006;13(3):141–6.
Akyüz-Ünsal, A.İ., et al., Retinopathy of prematurity risk factors: Does human milk prevent retinopathy of prematurity? Turkish Journal of Pediatrics, 2019. 61(1).
Boskabadi H, et al. Potential role of bilirubin in preventing retinopathy of prematurity. Curr Pediatr Rev. 2023;19(2):197–202.
pubmed: 35986544
doi: 10.2174/1573396318666220819151154
Chen JS, et al. Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment. Ophthalmol Sci. 2021;1(4): 100070.
pubmed: 36275192
pmcid: 9562374
doi: 10.1016/j.xops.2021.100070
Keles E, Bagci U. The past, current, and future of neonatal intensive care units with artificial intelligence: a systematic review. NPJ Digit Med. 2023;6(1):220.
pubmed: 38012349
pmcid: 10682088
doi: 10.1038/s41746-023-00941-5
Poppe JA, et al. Early prediction of severe retinopathy of prematurity requiring laser treatment using physiological data. Pediatr Res. 2023;94(2):699–706.
pubmed: 36788288
pmcid: 10382319
doi: 10.1038/s41390-023-02504-6
Lang DM, Blackledge J, Arnold RW. Is Pacific race a retinopathy of prematurity risk factor? Arch Pediatr Adolesc Med. 2005;159(8):771–3.
pubmed: 16061786
doi: 10.1001/archpedi.159.8.771
Phan, M.H., P.N. Nguyen, and J.D. Reynolds, Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. 2003, Slack Incorporated Thorofare, NJ. p. 208–212.
Gilbert C, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518–25.
pubmed: 15805336
doi: 10.1542/peds.2004-1180
The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9.
doi: 10.1001/archopht.123.7.991
Chen X, Ishwaran H. Random forests for genomic data analysis. Genomics. 2012;99(6):323–9.
pubmed: 22546560
doi: 10.1016/j.ygeno.2012.04.003
Azad R, et al. Retinopathy of prematurity: how to prevent the third epidemics in developing countries. The Asia-Pacific Journal of Ophthalmology. 2020;9(5):440–8.
pubmed: 32925293
doi: 10.1097/APO.0000000000000313
Vinekar A, et al. The changing scenario of retinopathy of prematurity in middle and low income countries: Unique solutions for unique problems. Indian J Ophthalmol. 2019;67(6):717.
pubmed: 31124475
pmcid: 6552588
doi: 10.4103/ijo.IJO_496_19
Shah V, et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34(2):169–78.
pubmed: 15827664
doi: 10.47102/annals-acadmedsg.V34N2p169
Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica. 2000;214(2):131–5.
pubmed: 10720918
doi: 10.1159/000027482
Owen LA, et al. Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease. PLoS ONE. 2017;12(2): e0171467.
pubmed: 28196114
pmcid: 5308834
doi: 10.1371/journal.pone.0171467
Barañano DE, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci. 2002;99(25):16093–8.
pubmed: 12456881
pmcid: 138570
doi: 10.1073/pnas.252626999
Kao JS, et al. Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity. Acta Paediatr. 2011;100(3):347–51.
pubmed: 20969622
doi: 10.1111/j.1651-2227.2010.02069.x
Fereshtehnejad, S.M., et al., Evaluation of the possible antioxidative role of bilirubin protecting from free radical related illnesses in neonates. Acta Medica Iranica, 2012: p. 153–163.
Eroglu SA, et al. The role of hepatic and renal functions in the development of retinopathy of prematurity: Is proteinuria a new risk factor? Int Ophthalmol. 2023;43(2):483–90.
pubmed: 35930082
doi: 10.1007/s10792-022-02445-9
Akkawi MT, et al. Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmol. 2019;19(1):189.
pubmed: 31429728
pmcid: 6701108
doi: 10.1186/s12886-019-1180-4
Geronimus AT. Black/white differences in the relationship of maternal age to birthweight: a population-based test of the weathering hypothesis. Soc Sci Med. 1996;42(4):589–97.
pubmed: 8643983
doi: 10.1016/0277-9536(95)00159-X
Fuchs F, et al. Effect of maternal age on the risk of preterm birth: A large cohort study. PLoS ONE. 2018;13(1): e0191002.
pubmed: 29385154
pmcid: 5791955
doi: 10.1371/journal.pone.0191002
Maravi P, et al. Influence of maternal factors on retinopathy of prematurity: A cross-sectional Study from a tertiary care centre. Indian Journal of Clinical and Experimental Ophthalmology. 2023;9(3):359–64.
doi: 10.18231/j.ijceo.2023.068
Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 2004;104(4):727–33.
pubmed: 15458893
doi: 10.1097/01.AOG.0000140682.63746.be
Russell RB, et al. The Changing Epidemiology of Multiple Births in the United States. Obstet Gynecol. 2003;101(1):129–35.
pubmed: 12517657
Cleary-Goldman, J., et al., Impact of maternal age on obstetric outcome. Obstetrics & Gynecology, 2005. 105(5 Part 1): p. 983–990.
Uchida, A., et al., Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. Journal of Ophthalmology, 2014. 2014.
Fortes Filho JB, et al. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010;248:893–900.
pubmed: 20016911
doi: 10.1007/s00417-009-1248-6
Estrada MM, et al. Daily Oxygen Supplementation and Risk of Retinopathy of Prematurity. Ophthalmic Epidemiol. 2023;30(3):317–25.
pubmed: 36093765
doi: 10.1080/09286586.2022.2111687
Rodriguez SH, et al. Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen. J Clin Med. 2023;12(3):1228.
pubmed: 36769876
pmcid: 9918247
doi: 10.3390/jcm12031228
Hellström A, Hård A-L. Screening and novel therapies for retinopathy of prematurity–A review. Early Human Dev. 2019;138: 104846.
doi: 10.1016/j.earlhumdev.2019.104846
Vatne, A., et al., Early empirical antibiotics and adverse clinical outcomes in infants born very preterm: a population-based cohort. The Journal of Pediatrics, 2023. 253: p. 107–114. e5.
Greenwood C, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr. 2014;165(1):23–9.
pubmed: 24529620
pmcid: 4074569
doi: 10.1016/j.jpeds.2014.01.010
Cantey JB, Sánchez PJ. Prolonged antibiotic therapy for “culture-negative” sepsis in preterm infants: it’s time to stop! J Pediatr. 2011;159(5):707–8.
pubmed: 21885065
doi: 10.1016/j.jpeds.2011.07.032
Fjalstad JW, et al. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2017;73(3):569–80.
doi: 10.1093/jac/dkx426
Pivodic A, et al. Prognostic value of parenteral nutrition duration on risk of retinopathy of prematurity: development and validation of the revised DIGIROP clinical decision support tool. JAMA ophthalmology. 2023;141(8):716–24.
pubmed: 37382945
pmcid: 10311427
doi: 10.1001/jamaophthalmol.2023.2336
Petrachkova M, et al. Modern approaches to predicting the development of active type 1 retinopathy of prematurity. Vestn oftalmol. 2019;135(4):50–9.
pubmed: 31573557
doi: 10.17116/oftalma201913504150
Wu P-Y, et al. Systemic Cytokines in Retinopathy of Prematurity. Journal of Personalized Medicine. 2023;13(2):291.
pubmed: 36836525
pmcid: 9966226
doi: 10.3390/jpm13020291
Bucher F, et al. CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2016;57(10):4017–26.
pubmed: 27494343
pmcid: 4986766
doi: 10.1167/iovs.15-18508
Soll, R. and E. Özek, Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane database of systematic reviews, 2009(1).
Been, J.V., et al., Chorioamnionitis alters the response to surfactant in preterm infants. The Journal of pediatrics, 2010. 156(1): p. 10–15. e1.
Hobar JD, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989;320(15):959–65.
doi: 10.1056/NEJM198904133201502
Coshal H, et al. Characteristics and outcomes of preterm neonates according to number of doses of surfactant received. J Perinatol. 2021;41(1):39–46.
pubmed: 32792633
doi: 10.1038/s41372-020-00779-9
Zarei M, et al. Prevalence and risk factors of retinopathy of prematurity in Iran. J Ophthalmic Vis Res. 2019;14(3):291.
pubmed: 31660108
pmcid: 6815327
Kang EY-C, et al. Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study. Invest Ophthalmol Vis Sci. 2018;59(8):3599–607.
pubmed: 30025087
doi: 10.1167/iovs.18-24020
Hamid, O., et al., Application of random survival forest for competing risks in prediction of cumulative incidence function for progression to AIDS. Epidemiology, Biostatistics, and Public Health, 2017. 14(4).
Hamidi O, et al. Identifying important risk factors for survival in kidney graft failure patients using random survival forests. Iran J Public Health. 2016;45(1):27.
pubmed: 27057518
pmcid: 4822390
Najafi-Vosough R, et al. Prediction the survival of patients with breast cancer using random survival forests for competing risks. J Prev Med Hyg. 2022;63(2):E298.
pubmed: 35968067
pmcid: 9351408
Omurlu IK, Ture M, Tokatli F. The comparisons of random survival forests and Cox regression analysis with simulation and an application related to breast cancer. Expert Syst Appl. 2009;36(4):8582–8.
doi: 10.1016/j.eswa.2008.10.023
Tapak L, et al. Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests. J Prev Med Hyg. 2020;61(3):E482.
pubmed: 33150237
pmcid: 7595073
Adham D, Abbasgholizadeh N, Abazari M. Prognostic factors for survival in patients with gastric cancer using a random survival forest. Asian Pacific journal of cancer prevention: APJCP. 2017;18(1):129.
pubmed: 28240020
pmcid: 5563089
van Zutphen M, et al. Identification of lifestyle behaviors associated with recurrence and survival in colorectal cancer patients using random survival forests. Cancers. 2021;13(10):2442.
pubmed: 34069979
pmcid: 8157840
doi: 10.3390/cancers13102442